insights_auto
Why is TCRX down 3.08%?
Dive Deeperchevron_right
TCRX:NASDAQ
Tscan Therapeutics Inc
$0.29
arrow_downward
-3.08%(-0.0091) 1D
Oct 6, 9:58:44 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TCRX...
Open
$0.29
High
$0.30
Low
$0.29
Mkt. cap
20.72M
Avg. vol.
1.04M
Volume
46.15K
52-wk high
$2.57
52-wk low
$0.28
EPS
-$0.91
Beta
1.15
Shares outstanding
63.50M
No. of employees
138
Open
$0.29
High
$0.30
Low
$0.29
Mkt. cap
20.72M
Avg. vol.
1.04M
Volume
46.15K
52-wk high
$2.57
52-wk low
$0.28
EPS
-$0.91
Beta
1.15
Shares outstanding
63.50M
No. of employees
138
News stories
From web sources and news partners
Newswire
·
15 minutes ago
FatPipe, Inc. (NASDAQ: FATN) to Attend the 2026 Maxim Growth Summit
The Pharma Letter
·
40 minutes ago
TRex Bio sets terms for Nasdaq IPO of up to $128.7 million, with Lilly eyeing stake
The Daily News | Texas' Oldest Newspaper
·
19 minutes ago
A trader works on the floorat the New York Stock Exchange (NYSE) in New York City
Yahoo Finance
·
54 minutes ago
RedCloud will Hold General Meeting of Shareholders on October 30, 2026
About Tscan Therapeutics Inc
CEO-
Employees138
Founded2018
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitetscan.com